Elvis Torres
Obstetrics & Gynecology · Houston, TXNPI 1225146491
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 32.0% of the total. Reporting peaked in 2019 at $690 and has fallen 78.5% since, to $149 in 2025.
Across 112 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$807
- Mayne Pharma Commercial LLC$332
- Exeltis, USA Inc.$264
- Avion Pharmaceuticals$145
- Evofem Biosciences, Inc.$97
- Astellas Pharma US Inc$92
- plus $785 from 21 others
Across 18 payments — averaging $2150.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$39K
What the payments were for
- Food & beverage$2,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $807 |
| Mayne Pharma Commercial LLC | 14 | $332 |
| Exeltis, USA Inc. | 12 | $264 |
| Avion Pharmaceuticals | 9 | $145 |
| Evofem Biosciences, Inc. | 5 | $97 |
| Astellas Pharma US Inc | 5 | $92 |
| Hologic Sales And Service, LLC | 5 | $81 |
| Medtronic | 1 | $76 |
| Johnson & Johnson | 2 | $65 |
| Shield Therapeutics Inc | 4 | $62 |
| Pfizer | 3 | $57 |
| Baxter Healthcare | 1 | $49 |
| Myovant Sciences Inc. | 3 | $42 |
| Sage Therapeutics, LLC | 2 | $40 |
| Merck | 2 | $37 |
| Mission Pharmacal Company | 2 | $36 |
| Coopersurgical, Inc. | 2 | $32 |
| Mylan Pharmaceuticals Inc. | 2 | $32 |
| Smith+Nephew | 1 | $31 |
| Exact Sciences | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $20 |
| Optumhealth Care Solutions, LLC | 1 | $18 |
| Scynexis, Inc. | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $15 |
| Organon | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$351
- NEXTSTELLIS$123
How this compares
$2,523 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.